Description
A specific inhibitor of the proteolytic activity of Omi/HtrA2 (IC50 = 9.5 µM) that is naturally fluorescent, thus enabling the visualization of its entry into cells; has been reported to decrease cerebral infarct size in a rat model of cerebral ischemia and to be protective of cardiomyocytes against ischemic injury